Back to Daily DR Market Summary

StreetAccount Summary - Asian Market Preview: Nikkei Futures (1.24%), Hang Seng Futures +0.12%, ASX SPI 200 (0.44%), S&P Futures (0.06%)

Jul 07 ,2026

  • Synopsis:

    • Asian markets set for negative start to Wednesday trade. Futures signaling steep opening losses in Japan and South Korea and flat start in Hong Kong. ASX futures saw mild declines in comparison. S&P 500 futures flat following tech/semi-led retreat on Tuesday. Australian bonds weakening after Treasury yields backed up overight. Crude extending rebound to two-week high. Gold and silver adding to earlier declines. Dollar inching higher against yen. Bitcoin little changed.

    • Volatility in momentum trade continued with SOX swinging down by 5%. Follows big memory selloff in Asia on Tuesday led by Samsung Electronics after its preliminary Q2 failed to clear high earnings bar. Backup in yields/oil rebound mentioned as a drag amid latest Hormuz flare-up and there was some attention to reports DeepSeek to develop its own AI chips. Memory volatility being viewed as a function of crowded longs being unwound, encouraging rotation into other sectors.

    • RBNZ expected to hike OCR by 25 bp to 2.50% Expectations for July rate hike supported by inflation risks that are shaping concerns about an unanchoring of inflation expectations. Any rate hike expected to be accompanied by forward guidance hinging further moves on incoming data, though some economists expect RBNZ to take OCR to neutral 3.00% by end-2026. In Reuters interview, BOJ board member and reflationist Asada said he wanted to signs of demand-driven inflation before supporting rate hikes.

  • Pre-open Company News:

    • SDI.AU -- Shandong Sinocera Functional Material completes privatization of SDI at A$1.4/share

    • 603893.CH -- Rockchip Electronics guides H1 net income attributable CNY850-910M vs year-ago CNY531.2M

    • 8153.JP -- MOS FOOD SERVICES reports June MOS BURGER same-store sales +1.4% y/y

    • KLRA -- Kailera Therapeutics announces topline data from two Hengrui Pharma Phase 3 clinical trials of oral small molecule GLP-1 receptor agonist HRS-7535/KAI-7535

    • 6875.JP -- MegaChips completes up-to-¥10.00B buyback

    • 9971.HK -- BASiC Semiconductor's 27.4M-share Hong Kong IPO priced at HK$31.62/share

    • 300498.CH -- Wen's Foodstuff Group provides June sales update

    • 000725.CH -- BOE Technology Group upgraded to buy from hold at HSBC

    • 3759.HK -- Pharmaron Beijing initiated buy at Daiwa

    • 532539.IN -- Uno Minda approves INR3.20B for 4W passenger vehicle seating systems segment

    • 000539.CH -- Guangdong Electric Power Development to raise CNY4.5-5.0B from offshore wind farm REIT listing

    • 2610.TT -- China Airlines upgraded to buy from neutral at Fubon Securities

    • 2386.HK -- SINOPEC Engineering (Group) upgraded to buy from neutral at BofA

    • 8697.JP -- Japan Exchange completes up-to-¥20.00B buyback

  • On Deck:

    • Japan:

      • Economic:

        • 08:50 JST: Bank Loans NSA Y/Y; consensus

      • Earnings:

        • TSURUHA Holdings (3391.JP), ABC-MART (2670.JP), BELLSYSTEM24 Holdings (6183.JP), Life Corp. (8194.JP), Yoshinoya Holdings (9861.JP)

    • Thailand:

      • Earnings:

        • AEON Thana Sinsap (Thailand) Public (AEONTS.TB)

  • Market Data:

    • Gold (Aug 26): ($41.50) or (1.00%) to $4115.90

    • WTI Crude (Aug 26): +$2.04 or +2.90% to $72.48

    • $-¥: +0.21 or +0.13% to 162.2940

    • $-KRW: (13.17) or (0.86%) to 1515.7500

    • A$-$: (0.00) or (0.40%) to 0.6924

    • $-INR: +0.19 or +0.20% to 95.5934

    • $-CNY: (0.00) or (0.05%) to 6.7932

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE